EGFR and non-small cell lung carcinoma: Rebiopsy, either liquid biopsy or direct tissue biopsy, for secondary T790M detection is recommended as standard care for advanced EGFR-mutated NSCLC with acquired resistance to 1st/2nd-generation EGFR-TKIs (21–26).